Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

Learn how Nebraska Medical Center treats patients with cancer in the same institution where the most serious COVID-19 patients receive treatment at the Nebraska Biocontainment Unit.
In April at the virtual 2020 Community Oncology Alliance Annual Conference, leaders across the cancer care community gathered online for a panel discussion of current events and policy priorities in oncology care. COVID-19 and its fallout on community cancer centers dominated the discussion, which was moderated by Ted Okon, MBA, the executive director of the Community Oncology Alliance (COA). Okon …
Disclosures: None Pectoralis muscle wasting during chemotherapy Jason Wiederin, MD1, Christina Gu, MS2, Patricia Jewett, PhD2, Anne Blaes, MD2 Hennepin Healthcare1, University of Minnesota2 Females N = 323 Mean (SD) Males N = 164 Mean (SD) Age at baseline CT, years 60.7 (10) 62.3 (10.2) BMI 28.3 (6.4) 29.3 (5.3) Right pectoralis, cm2 14.9 (4.3) 26.3 (8.8) N (%) N(%) Cancer …
Slide 1 Se young Han¹, Celalettin Ustun², Fiona He¹ Division of Hematology Oncology and Transplant, University of Minnesota, Minneapolis MN, USA¹ Division of Hematology Oncology and Cellular therapy, Rush University, Chicago, IL, USA² ■ Cytogenetic abnormalities at diagnosis is a crucial prognostic marker in patients with acute myeloid leukemia. ■ Cytogenetic evolution (CE) is defined …
Slide 1 A Case of Plasma Cell Leukemia Presenting as Renal Failure with Heavy Proteinuria Marie Hu, MD1 and Daniel Pease, MD2 1University of Minnesota Department of Hematology, Oncology, and Transplant 2Hennepin Healthcare Comprehensive Cancer Center Case Presentation Case Resolution • A 48-year-old woman with history of stage II breast cancer was admitted with acute kidney …
PowerPoint Presentation Effects of Genetic Polymorphism on Pharmacokinetics of Cyclophosphamide in Conditioning Regimen for Adult Hematopoietic Cell Transplant Patients Takuto Takahashia,b, Rachael Pearsonc, Qing Caod, Pamala Jacobsonb aDivision of Pediatric Hematology/Oncology/Blood and Marrow Transplant, bDepartment of Experimental and Clinical Pharmacology, cCollege of …
Slide 1 Impact of antibiotics on residual cancer burden and pathologic response rates during neoadjuvant Pembrolizumab in breast cancer Amit Kulkarni1, Patricia Jewett1, Anne Blaes1, Douglas Yee1 1Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN BACKGROUND • Achieving pathologic complete response (pCR) following neoadjuvant chemotherapy …
PowerPoint Presentation Colon cancer has been reported to occur early in certain African regions, but the understanding of the genetic modifications leading to early disease is incomplete. Here we present a study cases of early colon cancer and genetic modifications leading to these tumors in Ethiopia High Incidence of Early Onset Colorectal cancer in Ethiopia: Clinical and Therapeutic …
Sample research poster Localization patterns and survival of extranodal NK/T-cell lymphomas in the United States: A population-based study of 945 cases Objective Daniel O’Leary M.D., Nikhil Goyal B.S.1, Nathan Rubin M.S.2, Kimberly Bohjanen M.D.,3 Amrita Goyal M.D.3 Conclusions Table 2: Survival Background Extranodal natural killer/T-cell lymphomas (eNK/TCLs) are …
Sample research poster Surgical management and lymph node biopsy of rare malignant cutaneous adnexal carcinomas: a population-based analysis of 7591 patients Surgical Management Amrita Goyal MD, 1 Theodore Marghitu,2 Nikhil Goyal BS,3 Nathan Rubin MS,4 Krishnan Patel MD,6 Kavita Goyal MD,1 Daniel O’Leary MD,5 Kimberly Bohjanen MD, 1 Ian Maher MD 1 Objective, Design, & Participants …
Slide 1 • Data Sources: PubMed and Cochrane database till December 31, 2018 • Study Selection: We included observational studies and randomized trials that evaluated association of BMI with pCR in operable breast cancer patients that underwent NACT. • Data Extraction and Analysis: Two authors independently extracted data and rated the study quality. induced Adaptive NK cells …
PowerPoint Presentation An Electronic Medical Record Intervention to Improve Inpatient Appropriate VTE Prophylaxis Westergard, E.1, Patel, L.2, Miller, M.2, Wohlwend, L.1, Ornes, M.1 1Abbott Northwestern Hospital, Department of Graduate Medical Education, Minneapolis MN 2Abbott Northwestern Hospital, Department of Internal Medicine, Minneapolis MN BACKGROUND Venous thromboembolism …
PowerPoint Presentation Fig 1. Antibiotic exposures. Antibiotic exposures by day +14 (A) and +100 (B). Antibacterial antibiotic exposures and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation Shijia Zhang MD, PhD1, Ryan Shanley MS2, and Armin Rashidi MD, PhD1 1Division of Hematology, Oncology and Transplantation, Department of Medicine, University …
Slide 1 High Risk of Relapse with Intermediate Dose Cytarabine for Consolidation in Young Favorable Risk AML Patients following Induction with 7+3 Bhaskar Kolla, NAA Halim, Qing Cao, Zohar Sachs, Erica Warlick, Daniel Weisdorf, William Hwang, Fiona He, Zhentang Lao METHODS INTRODUCTION RESULTS Using single agent IDAC for post remission therapy is associated with higher rates …
Chimeric Antigen Receptor T-cell Therapy for HIV-associated Diffuse Large B-cell Lymphoma: Case Report and Management Recommendations Jeremy Allred1, Kharmen Bharucha2, Can Özütemiz3, Fiona He1, Murali Janakiram1, Joseph Maakaron1, Claire Carrier1, Bartosz Grzywacz4, Veronika Bachanova1. 1) Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis …
PowerPoint Presentation Optimizing Staffing Strategies Amid COVID-19 Amanda Henson, MSHA, MBA, FACHE System Vice President, Cancer Service Line Baptist Health Friday, May 29, 2020 This webcast is supported by educational grants from AstraZeneca Pharmaceuticals, Merck & Co., and Pfizer, Inc. Deirdre Saulet, PhD Expert Partner Advisory Board Company Cancer Programs …
CCMED_4_2_Infographic_May_29_2020 The Association of Community Cancer Centers (ACCC) developed a new benchmark for ideal NSCLC care through the national quality care initiative for patients with advanced (stage III/IV) NSCLC Evidence-Based Recommendations for the High-Quality Care of Patients with Non-Small Cell Lung Cancer Non-small cell lung cancer (NSCLC) accounts for …
May 29, 2020
Deirdre Saulet, Advisory Board Company, and Amanda Henson, MSHA, MBA, FACHE, Baptist Health, share an overview of programs’ volumes in response to COVID-19, effective staffing strategies, tactics for supporting your care team, and how to prepare for potential future ‘waves’. (May 29, 2020)
Rockville, MD—The Association of Community Cancer Centers (ACCC) is presenting seven abstracts at the American Society of Clinical Oncology 2020 (#ASCO20) Virtual Scientific Program, May 29 to May 31, 2020. The presentation of data spans across ACCC’s diverse Provider Education portfolio, featuring clinical and non-clinical studies in optimal lung cancer care delivery, comprehensive cancer care …
CCMED_3_2_Infographic_May_29_2020 Improving care for patients with stage III/IV NSCLC: learnings for multidisciplinary teams from the ACCC national quality survey Salgia et al. (2020) What are the barriers to effective MDT implementation and how can MDTs be optimized for NSCLC treatment? What Are the Barriers to Efficient Multidisciplinary Treatment of Stage III/IV Non-Small …